ReviewClinical endocrinology2011

Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Laszlo Hegedüs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.